Objectives Knowledge about the impact of body composition features on pharmacokinetics
of newer long-acting injectable antipsychotics is limited. Methods We analyzed steady-state …

Background It is well known that schizophrenia is associated with sex differences. However,
no study has explored the sex differences in obesity and cognitive function in elderly …

A esquizofrenia é considerada uma das grandes incógnitas do meio psiquiátrico por conta
da sua complexa fisiopatologia, sendo assim uma das doenças mais pesquisadas no …

Obesity induced by antipsychotics have plagued more than 20 million people worldwide.
However, no drug is available to eliminate the obesity induced by antipsychotics. Here we …

Background and Objective: Schizophrenia (SZ) is a chronic mental illness that is associated
with increased inflammation, adverse effects on the immune system, and abnormal …

OLZ (OLZ), a second-generation antipsychotic (SGA) is highly prescribed for patients
suffering from schizophrenia, bipolar disorder, and other “off-label” conditions such as …

Background: Although overweight and obesity are important risk factors for the physical
health of severe mental disorders (SMD), few studies have been reported. Morbidity and …

Introdução: Análises corporais mais específicas mostram que pacientes com esquizofrenia
também apresentam uma porcentagem de gordura mais elevada quando comparado a …

Schizophrenia is a severe mental illness, characterized by psychotic symptoms including
delusions, hallucinations, dystonia, adolescent behavior and language, and is accompanied …

Olanzapine (OLZ) is a second-generation antipsychotic that is used to treat schizophrenia
and other mental health disorders. While effective at reducing psychoses, OLZ induces …